Symposium on Advanced Wound Care (SAWC) Spring, held April 30–May 4, 2025, in Grapevine, TX. Juha Yrjänheikki (CEO) and Laurent Décory (COO) participated to meet with Advanced Wound Care companies to discuss potential partnerships, as well as with clinicians and KOLs to discuss clinical plans.
Share the event:
Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the Biotech Week Boston from 15-18 September 2025 in Boston, USA.
Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.
Baarerstrasse 21, CH-6300
Zug, Switzerland
Microkatu 1, FI-70210
Kuopio, Finland
This information will only be used to send you our newsletter. You can unsubscribe at any moment.
Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.